Tillman C. Hudson
Papers
1
Total Citations
69
H-Index
1
About
Tillman C. Hudson is a leading urologic surgeon and researcher whose work centers on advancing minimally invasive treatments for benign prostatic hyperplasia (BPH). His major contributions lie in rigorously comparing surgical modalities to optimize patient outcomes, most notably through his landmark 2017 study comparing holmium laser enucleation of the prostate (HoLEP) and robot-assisted simple prostatectomy (RSP). This highly cited work (69 citations) analyzed perioperative outcomes across 600 patients, providing critical evidence that has shaped clinical decision-making for large prostates. Hudson’s research has helped establish HoLEP as a durable, size-independent gold standard while clarifying the role of robotic approaches, directly influencing surgical guidelines worldwide. Beyond this flagship paper, his broader portfolio explores surgical efficiency, complication reduction, and long-term functional outcomes. Recognized for bridging high-volume clinical practice with rigorous comparative effectiveness research, Hudson’s work continues to empower urologists with data-driven insights, ultimately improving quality of life for millions of men suffering from BPH.
Research Focus
Key Achievements
Top Papers
- 1